V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014605 | 270010415 | 1.6 | 94 | Curative (C) | 2015-10-09 | 2015-10-09 | IBRUTINIB | 02 | Y | 270021161 | CARBOPLATIN + RT |
| 270014606 | 270010416 | null | 71.7 | Curative (C) | 2014-07-03 | 2015-04-18 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 270021161 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014607 | 270010417 | 1.62 | 59.9 | Curative (C) | 2015-08-17 | 2015-08-18 | Cisplatin + Pemetrexed | N | N | 270021196 | CISPLATIN + VINORELBINE |
| 270014608 | 270010418 | 1.88 | null | Curative (C) | 2017-07-17 | 2017-07-17 | LENALIDOMIDE | N | N | 270021203 | GEMCITABINE + OXALIPLATIN |
| 270014609 | 270010419 | 1.78 | 92.2 | Palliative (P) | 2016-03-10 | 2016-03-18 | R CODOX-M/ R IVAC | 2 | N | 270021238 | VENETOCLAX |
| 270014610 | 270010421 | 1.6 | 51.4 | Curative (C) | null | 2016-12-12 | PEMBROLIZUMAB | null | N | 270021271 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270014611 | 270010422 | 1.75 | null | Curative (C) | 2013-01-13 | 2013-04-09 | Bevacizumab + Irinotecan + MdG | 02 | N | 270021278 | CAPECITABINE + CARBOPLATIN |
| 270014612 | 270010422 | null | null | null | 2017-05-22 | 2017-05-31 | PEMBROLIZUMAB | null | N | 270021278 | CARBOPLATIN + RT |
| 270014613 | 270017201 | 1.74 | 69.9 | Curative (C) | 2019-02-08 | 2019-02-08 | Docetaxel | 2 | N | 270021304 | CARBO + FLUOROURACIL |
| 270014614 | 270010423 | 1.62 | 57 | Disease modification (D) | 2013-07-29 | 2013-08-26 | IBRUTINIB | 02 | N | 270021340 | SCOT TRIAL |
| 270014615 | 270014868 | 1.69 | 97.3 | Curative (C) | 2015-04-28 | 2015-05-15 | IBRUTINIB | 99 | null | 270021351 | CARBO + FLUOROURACIL |
| 270014616 | 270010425 | 1.79 | 87 | Curative (C) | 2014-09-24 | 2014-09-24 | FEC 100 | N | null | 270021355 | CARBOPLATIN + ETOPOSIDE |
| 270014617 | 270010426 | 1.73 | 75.8 | Not known (9) | 2015-01-12 | 2015-01-26 | Bevacizumab + Irinotecan + MdG | 02 | N | 270021359 | CAPECITABINE + OXALIPLATIN + RT |
| 270014618 | 270014869 | 1.91 | 56.6 | Curative (C) | 2013-11-13 | 2013-11-17 | Docetaxel 75mg/m2 (21 day) | N | N | 270021362 | GEFITINIB |
| 270014619 | 270014869 | null | 66.199 | Curative (C) | null | 2017-02-23 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | N | 270021362 | CETUXIMAB + CISPLATIN + FU |
| 270014620 | 270014869 | 1.7 | 83.6 | Curative (C) | 2018-07-08 | 2018-07-17 | BENDAMUSTINE + RITUXIMAB | 02 | N | 270021362 | DOCETAXEL |
| 270014621 | 270010428 | 1.72 | null | Curative (C) | 2017-08-28 | 2017-09-19 | SCOT TRIAL | N | null | 270021484 | FOXTROT TRIAL |
| 270014622 | 270017203 | 1.73 | null | Palliative (P) | null | 2015-04-01 | Bevacizumab + Cape + Oxali 21day | N | null | 270021486 | FOCUS4 TRIAL |
| 270014623 | 270010431 | 1.8 | 83 | Palliative (P) | null | 2017-09-10 | Bevacizumab+Irinotecan+Raltitrexed | N | null | 270021504 | CUFOX TRIAL |
| 270014624 | 270010432 | 1.78 | 73.8 | Curative (C) | 2019-01-11 | 2019-01-25 | OXALIPLATIN | 2 | N | 270021516 | DOCETAXEL |
| 270014625 | 270010434 | 1.8 | 52.3 | Disease modification (D) | 2016-02-10 | 2016-02-14 | Mitomycin Intravesical | 02 | N | 270021522 | SCOT TRIAL |
| 270014626 | 270010435 | null | null | Curative (C) | 2017-01-28 | 2017-02-03 | Trifluridine + Tipiracil + Trifluridine and Tipiracil | N | N | 270021527 | IFOSFAMIDE |
| 270014627 | 270017205 | null | null | Palliative (P) | 2017-10-26 | 2017-10-26 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 270021549 | BEVACIZUMAB + CAPECITABINE |
| 270014628 | 270017205 | null | 78 | Palliative (P) | null | 2018-01-08 | Bevacizumab + Cape + Irino 14day | null | N | 270021549 | CARBO + FLUOROURACIL |
| 270014629 | 270010436 | 1.64 | 61 | Curative (C) | 2018-01-26 | 2018-05-20 | Vinorelbine (oral) | null | N | 270021605 | FOXTROT TRIAL |
| 270014630 | 270010436 | 1.78 | 69 | Curative (C) | 2016-09-29 | 2016-10-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | 270021605 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 270014631 | 270010438 | 1.58 | 58 | Curative (C) | 2015-02-24 | 2015-03-01 | Cetuximab+Irinotecan (Cyc2 onwards) | 02 | N | 270021616 | GEMCARBO |
| 270014632 | 270014876 | 1.94 | null | Curative (C) | 2016-10-02 | 2016-10-14 | TRASTUZUMAB | 02 | N | 270021620 | CARBOPLATIN + ETOPOSIDE |
| 270014633 | 270014876 | 1.73 | null | Curative (C) | null | 2018-02-14 | CETUXIMAB + OXALIPLATIN | null | null | 270021620 | CARBOPLATIN + RT |
| 270014634 | 270010440 | null | 36.7 | Curative (C) | 2015-10-27 | 2015-11-07 | CARBOPLATIN + RT | 02 | N | 270021657 | FLUOROURACIL + RT |
| 270014635 | 270010440 | null | 49 | Curative (C) | 2013-11-28 | 2013-11-29 | CAPECITABINE + CETUXIMAB | 02 | N | 270021657 | IBRUTINIB |
| 270014636 | 270010441 | 1.56 | 57.2 | Palliative (P) | null | 2016-11-16 | CETUXIMAB + CISPLATIN + FU | N | N | 270021686 | CETUXIMAB + IRINOTECAN |
| 270014637 | 270010441 | 1.74 | 90 | Curative (C) | 2016-04-21 | 2016-04-29 | Ifosfamide PVI 1g/m2 14day | 02 | N | 270021686 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270014638 | 270010441 | 1.58 | 49.4 | null | 2018-04-17 | 2018-04-30 | AFLIBERCEPT | 2 | N | 270021686 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270014639 | 270010441 | 1.66 | 77 | Disease modification (D) | 2017-07-20 | 2017-07-20 | FOXTROT TRIAL | N | N | 270021686 | GEMCARBO |
| 270014640 | 270010442 | 1.83 | 69.9 | Palliative (P) | 2018-10-15 | 2018-10-21 | FOCUS4 TRIAL | N | N | 270021774 | CARBOPLATIN + CETUXIMAB + FU |
| 270014641 | 270014879 | 1.77 | 54.4 | Curative (C) | 2017-03-27 | 2017-05-29 | FOXTROT TRIAL | N | N | 270021785 | SCOT TRIAL |
| 270014642 | 270010443 | null | null | Curative (C) | 2014-05-01 | 2014-05-01 | IBRUTINIB | N | null | 270021799 | CAPECITABINE + CETUXIMAB |
| 270014643 | 270018533 | 1.73 | 31 | null | 2016-05-21 | 2016-06-23 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 270021829 | IBRUTINIB |
| 270014644 | 270010445 | 0 | 74 | Curative (C) | 2016-06-15 | 2016-06-17 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 270021842 | CARBO + FLUOROURACIL |
| 270014645 | 270010448 | 1.68 | 63 | Curative (C) | 2014-04-28 | 2014-04-28 | CARBOPLATIN + RT | 02 | N | 270021851 | FOXTROT TRIAL |
| 270014646 | 270010449 | 1.73 | 51.2 | Disease modification (D) | 2017-06-19 | 2017-06-19 | Bevacizumab + Capecitabine | N | N | 270021896 | CETUXIMAB + IRINOTECAN |
| 270014647 | 270010449 | 1.63 | 71.1 | null | 2017-06-24 | 2017-06-24 | RATHL TRIAL | N | N | 270021896 | CHLVPP/PABLOE |
| 270014648 | 270010450 | 1.64 | 106.7 | Curative (C) | 2016-02-05 | 2016-02-06 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 02 | N | 270021910 | CAPECITABINE + MITOMYCIN |
| 270014649 | 270010451 | null | 59 | Curative (C) | 2017-05-18 | 2017-05-18 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | N | 270021944 | CAPECITABINE + OXALIPLATIN + RT |
| 270014650 | 270010452 | 1.75 | 56 | Palliative (P) | 2017-11-06 | 2017-11-27 | CETUXIMAB + CISPLATIN + FU | N | N | 270021968 | IVADO |
| 270014651 | 270010452 | 1.79 | 58 | Curative (C) | 2014-12-01 | 2014-12-08 | BEVACIZUMAB + FLUOROURACIL | N | N | 270021968 | BORTEZOMIB |
| 270014652 | 270010453 | 1.75 | 124.3 | Palliative (P) | null | 2017-03-07 | IRINOTECAN + MDG + PANITUMUMAB | Y | N | 270022047 | REGORAFENIB |
| 270014653 | 270014886 | 1.78 | 63.4 | Curative (C) | 2017-05-13 | 2017-05-15 | CARBOPLATIN + GEMCITABINE | 02 | N | 270022064 | PEMETREXED |
| 270014654 | 270010456 | 1.65 | 59.9 | Curative (C) | 2017-02-04 | 2017-04-10 | Vinorelbine (oral) | 2 | N | 270022072 | FOXTROT TRIAL |